Berchuck A - Search Results

1

Growth regulation and transformation of ovarian epithelium.

Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC Jr. Berchuck A, et al. Cancer. 1993 Jan 15;71(2 Suppl):545-51. doi: 10.1002/cncr.2820710209. Cancer. 1993. PMID: 8420675 Review.

2

Ha-ras polymorphisms in epithelial ovarian cancer.

O'Briant K, Chrysson N, Hunter V, Tyson F, Tanner M, Daly L, George SL, Berchuck A, Soper J, Fowler W, et al. O'Briant K, et al. Among authors: berchuck a. Gynecol Oncol. 1992 Jun;45(3):299-302. doi: 10.1016/0090-8258(92)90308-6. Gynecol Oncol. 1992. PMID: 1351862

3

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

4

Ploidy analysis of epithelial ovarian cancers using image cytometry.

Berchuck A, Boente MP, Kerns BJ, Kinney RB, Soper JT, Clarke-Pearson DL, Bast RC Jr, Bacus SS. Berchuck A, et al. Gynecol Oncol. 1992 Jan;44(1):61-5. doi: 10.1016/0090-8258(92)90013-9. Gynecol Oncol. 1992. PMID: 1370427

5

Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery.

Rodriguez GC, Soper JT, Berchuck A, Oleson J, Dodge R, Montana G, Clarke-Pearson DL. Rodriguez GC, et al. Among authors: berchuck a. J Clin Oncol. 1992 Oct;10(10):1553-60. doi: 10.1200/JCO.1992.10.10.1553. J Clin Oncol. 1992. PMID: 1383433

6

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: berchuck a. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

7

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

8

Mutations of the Ki-ras oncogene in endometrial carcinoma.

Ignar-Trowbridge D, Risinger JI, Dent GA, Kohler M, Berchuck A, McLachlan JA, Boyd J. Ignar-Trowbridge D, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Jul;167(1):227-32. doi: 10.1016/s0002-9378(11)91663-9. Am J Obstet Gynecol. 1992. PMID: 1442931

9

Biology and therapy with biologic agents in gynecologic cancer.

Wiener JR, Berchuck A, Bast RC Jr. Wiener JR, et al. Among authors: berchuck a. Curr Opin Oncol. 1992 Oct;4(5):946-54. doi: 10.1097/00001622-199210000-00020. Curr Opin Oncol. 1992. PMID: 1457511 Review.

10

Oncogenes in ovarian cancer.

Berchuck A, Kohler MF, Bast RC Jr. Berchuck A, et al. Hematol Oncol Clin North Am. 1992 Aug;6(4):813-27. Hematol Oncol Clin North Am. 1992. PMID: 1500387 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters